A dual GLP−1/GIP agonist may encompass the beneficial effects of both incretins on pancreatic beta cell function in the absence of beta−arrestin2 - Université de Montpellier Accéder directement au contenu
Communication Dans Un Congrès Année : 2021

A dual GLP−1/GIP agonist may encompass the beneficial effects of both incretins on pancreatic beta cell function in the absence of beta−arrestin2

Safia Costes
  • Fonction : Auteur
  • PersonId : 1082458
Stéphane Dalle
Gyslaine Bertrand
Magalie A Ravier
Fichier non déposé

Dates et versions

hal-03811309 , version 1 (11-10-2022)

Identifiants

  • HAL Id : hal-03811309 , version 1

Citer

Nour Zaimia, Safia Costes, Stéphane Dalle, Gyslaine Bertrand, Magalie A Ravier. A dual GLP−1/GIP agonist may encompass the beneficial effects of both incretins on pancreatic beta cell function in the absence of beta−arrestin2. European Association for the Study of Diabetes 2021, 2021, Vienne, Austria. ⟨hal-03811309⟩
10 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More